In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 212-214

  Welsh, Laura ^a   Gaydos, Charlotte ^a   Quinn, Thomas C ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0030032267     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.212     Document Type: Article

References (17)

1. Andrews, J. M., D. Honeybourne, I. Greaves, D. R. Baldwin, et al. 1992 Clarithromycin levels in human bronchial mucosa, alveolar macrophages, and serum [abstract] Presented at the Mediterranean Chemotherapy Congress 1992, Athens, Greece.
2. Baldwin, D. R., R. Wise, J. M. Andrews, J. P. Ashby, and D. Honeybourne. 1990. Azithromycin concentrations at the site of pulmonary infection. Eur. Respir. J. 3:886-890.
3. Block, S., J. Hedrick, M. R. Hammerschlag, G. H. Cassell, et al. 1995. Mycoplasma pneumontae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin cthylsuccinate. Pediatr. Infect. Dis. J 14:471-477.
4. British Thoracic Society. 1993 Guidelines for the management of community-acquired pneumonia in adults admitted to hospital Br J Hosp. Med. 49:346-350.
5. Centers for Disease Control. 1993. Sexually tiansmitted disease treatment guidelines. Morbid Mortal. Weekly Rep. 43:1-102.
6. Chirgwin, K., P. M. Roblin, and M. R. Hammerschlag. 1989. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR) Antimicrob. Agents Chemother. 33:1634-1635.
7. Fraschini, F., F. Scaglione, G. Pintucci, G. Maccarinelli, S. Dugnani, and G. Demartini. 1991. The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans J. Antimicrob. Chemother. 27(Suppl. A):61-65.
8. Grayston, J. T., L. A. Campbell, C. C. Kuo, C. H. Mordhorst, P. Saikku, D. H. Thom, and S. P. Wand. 1990. New respiratory tract pathogen: Chlamydia pneumoniae strain TWAR J. Infect Dis. 161:618-625.
9. Grayston, J. T., C. C. Kuo, S. P. Wang, and J. Altman. 1986. A new Chlamydia psittact strain. TWAR, isolated in acute respiratory tract infections N. Engl J. Med. 315:161-168.
10. Hammerschlag, M. R. 1994. Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae. Antimicrob. Agents Chemother. 38:1873-1878.
11. Hammerschlag, M. R., K. K. Qumei, and P. M. Roblin. 1992. In vitro activities of azithromycin. clarithromycin. L-ofloxacin, and other antibiotics against Chlamydia pneumoniae Antimicrob. Agents Chemothcr. 36:1573-1574
12. Mourad, A., R. L. Sweet, N. Sugg, and J. Schachter. 1980. Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob. Agents Chemother. 18:696-698
13. Mundy, L., P. G. Auwaerter, D. Oldach, M. L. Warner, A. Burton, E. Vance, C. A. Gaydos, J. M. Joseph, R. Gopalan, R. D. Moore, T. C. Quinn, P. Charache, and J. G. Bartlett. 1995. Community-acquired pneumonia: impact of immunological status. Am. J. Rcspir. Crit. Care Med. 152:1309-1315
14. Roblin, P. M., G. Montalban, and M. R. Hammerschlag. 1994. Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. Antimicrob. Agents Chemother. 38:1588-1589
15. Rodvold, K. A., and S. C. Piscitelli. 1993. New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics. interactions and safety. Clin Infect Dis. 17:S192-S199.
16. Walsh, M., E. W. Kappas, and T. C. Quinn. 1987. In vitro evaluation of CP-62,993. erythromycin. clindamycin. and tetracycline against Chlamydia trachomatis. Antimicrob. Agents Chemother. 31:811-812
17. Welsh, L. E., C. A. Gaydos, and T. C. Quinn. 1992. In vitro evaluation of activities of azithromycin, crythromycin. and tetracycline against Chlamydia trachomatis and Chlamydia pneumomae. Antimicrob. Agents Chemother. 36:291-294.